Literature DB >> 16678710

Pretreatment with dextran 1 makes dextran 40 therapy safer.

Karl-Gösta Ljungström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678710     DOI: 10.1016/j.jvs.2005.11.056

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


× No keyword cloud information.
  5 in total

1.  Low-molecular-weight dextran-induced anaphylactic shock immediately after intracoronary imaging.

Authors:  Kazuoki Dai; Kuniomi Oi; Yohei Hyodo; Yusuke Jyuri; Shin Takayama; Mikio Shigehara; Shunsuke Tomomori; Tadanao Higaki; Tomoharu Kawase; Kazuyoshi Suenari; Kenji Nishioka; Masaya Otsuka; Yoshiko Masaoka; Nobuo Shiode; Yukiko Nakano
Journal:  J Cardiol Cases       Date:  2022-06-04

Review 2.  Sugar-based biopolymers as novel imaging agents for molecular magnetic resonance imaging.

Authors:  Zheng Han; Guanshu Liu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-01-22

3.  Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage.

Authors:  Tohru Shiratori; Atsushi Sato; Masao Fukuzawa; Naoko Kondo; Shogo Tanno
Journal:  Case Rep Crit Care       Date:  2015-06-11

4.  Effects of different plasma expanders on rats subjected to severe acute normovolemic hemodilution.

Authors:  Guo-Xing You; Bing-Ting Li; Zhen Wang; Quan Wang; Ying Wang; Jing-Xiang Zhao; Lian Zhao; Hong Zhou
Journal:  Mil Med Res       Date:  2020-11-11

5.  Introducing iron isomaltoside 1000 (Monofer®)-development rationale and clinical experience.

Authors:  Philip A Kalra
Journal:  NDT Plus       Date:  2011-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.